Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

A High-throughput System for Blood Fractionation

By Drug Discovery Trends Editor | January 11, 2013

Hamilton Robotics has introduced the Microlab easyBlood STARlet workstation, a fully automated system for blood fractionation in biobanking applications.

The easyBlood STARlet workstation effectively eliminates error-prone manual pipetting steps and increases the safety of precious biobanking samples with state-of-the-art imaging technology, excellent pipetting capabilities, and powerful sample tracking software. 

The easyBlood system is a high-throughput, fully integrated workstation that enables technicians to reliably pipet the desired layer of primary blood samples, including the buffy coat. The system is compatible with laboratory information management systems (LIMS), offers full traceability by ensuring that data can be linked confidently to each sample, and enables a seamless biobanking workflow. 

The easyBlood STARlet system is manufactured in Hamilton’s Bonaduz, Switzerland facility and is based on the compact Hamilton Robotics Microlab STARlet platform. The world-leading Hamilton STAR line of instruments offers laboratories the greatest flexibility in liquid handling application design, including heating and cooling devices, multi-channel heads, and HEPA hoods. The easyBlood STARlet workstation offers customers the ability to fractionate blood from a multitude of primary sample tubes to a variety of 2D-barcoded and storage-ready target containers found in today’s biobanks.

The comprehensive easyBlood STARlet system includes all required components and software  for reading and loading barcoded, decapped samples and additional labware such as plates and pipette tips. The instrument’s high-resolution, camera-based fraction identification detects difficult targets, such as buffy coats and gel separators in centrifuged samples. The system provides complete control and monitoring of the pipetting process with software-enabled adjustment of pipetting speed to suit specific liquid classes. All three fractions (plasma, buffy coat, and red blood cells) are pipetted and aliquoted as desired. 

The easyBlood workstation also integrates with the -80°C BiOS third-generation automated storage system, which was designed for sample integrity and superior service. 

Hamilton Robotics


Filed Under: Drug Discovery

 

Related Articles Read More >

Sanders, King target DTC pharma ads but the industry worries more about threats to its $2B R&D model
Zoliflodacin wins FDA nod for treatment of gonorrhea
FDA approved ENFLONSIA for the prevention of RSV in Infants
First clinical study results of Dupixent for atopic dermatitis in patients with darker skin tones 
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE